Full access to all news articles, including in-depth analysis and opinion pieces.
Exclusive interviews with experts and influential figures.
Enhanced multimedia experience with videos, photo galleries, and interactive graphics.
Ad-free browsing for a seamless reading experience.
Global Insights
$
$
9.99
$
0
/ 30 days
/ 30 days
placeholder text
Global Insights Subscription:
All features of the Premium Subscription.
Exclusive access to monthly webinars or live Q&A sessions with our journalists and correspondents, providing insights into the news-gathering process and global events.
Customizable news alerts tailored to your specific interests and regions.
Early access to special investigative reports and in-depth features.
10 things to watch Friday, Sept. 27 1. The S & P 500 was looking at a slightly higher open Friday after another record high close. The 10-year Treasury...
Dr. Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. He is a CNBC contributor and is a member of...
Neurotech start-up Paradromics will be trialing its brain implant next year, as the race to be the leader in the nascent brain-computer interface (BCI) space heats up."The brain is...
In this photo illustration, UnitedHealth Group Inc logo seen displayed on a tablet.Igor Golovniov | Sopa Images | Lightrocket | Getty ImagesChange Healthcare on Friday said it's finished setting...
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March...
Illegal migrant border encounters have plummeted since President Donald Trump took office in January and continue to trend at record lows compared to...